Search

Your search keyword '"Anto, Josep M."' showing total 101 results

Search Constraints

Start Over You searched for: Author "Anto, Josep M." Remove constraint Author: "Anto, Josep M." Topic asthma Remove constraint Topic: asthma
101 results on '"Anto, Josep M."'

Search Results

1. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).

2. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases.

3. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study.

4. Green Roof Gardens - Selecting Allergy-Friendly Vegetation: A Global Allergy and Asthma Excellence Network (GA²LEN) Position Paper.

5. Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study.

6. Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study.

7. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

8. Cutoff Values of MASK-air Patient-Reported Outcome Measures.

9. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study.

10. Creatine Kinase Is Decreased in Childhood Asthma.

11. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis.

12. Development and validation of combined symptom-medication scores for allergic rhinitis.

14. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).

15. Shared DNA methylation signatures in childhood allergy: The MeDALL study.

16. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

17. A demonstration project of Global Alliance against Chronic Respiratory Diseases: Prediction of interactions between air pollution and allergen exposure-the Mobile Airways Sentinel NetworK-Impact of air POLLution on Asthma and Rhinitis approach.

18. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.

19. Understanding allergic multimorbidity within the non-eosinophilic interactome.

20. 2019 ARIA Care pathways for allergen immunotherapy.

21. Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later.

22. Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course.

23. [MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries].

24. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

25. Integrating Clinical and Epidemiologic Data on Allergic Diseases Across Birth Cohorts: A Harmonization Study in the Mechanisms of the Development of Allergy Project.

26. DNA methylation in childhood asthma: an epigenome-wide meta-analysis.

27. Maternal Smoking during Pregnancy and Early Childhood and Development of Asthma and Rhinoconjunctivitis - a MeDALL Project.

28. Genetic and epigenetic regulation of YKL-40 in childhood.

29. Prevalence of asthma-like symptoms with ageing.

30. Assessment of thunderstorm-induced asthma using Google Trends.

32. Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study.

33. The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease?

34. Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway.

35. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop.

36. Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts.

38. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort.

39. Early-life allergen exposure and atopy, asthma, and wheeze up to 6 years of age.

40. Severe asthma in adults: what are the important questions?

41. Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®.

42. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study.

45. Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases—POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WH0) demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing

46. The ARIA-MASK-air® approach

47. POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project

49. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach.

50. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air (R)

Catalog

Books, media, physical & digital resources